Log in to save to my catalogue

Effect of the single CYP2C93 allele on pharmacokinetics and pharmacodynamics of losartan in healthy...

Effect of the single CYP2C93 allele on pharmacokinetics and pharmacodynamics of losartan in healthy...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71359641

Effect of the single CYP2C93 allele on pharmacokinetics and pharmacodynamics of losartan in healthy Japanese subjects

About this item

Full title

Effect of the single CYP2C93 allele on pharmacokinetics and pharmacodynamics of losartan in healthy Japanese subjects

Publisher

Heidelberg: Springer

Journal title

European journal of clinical pharmacology, 2003-11, Vol.59 (8-9), p.589-592

Language

English

Formats

Publication information

Publisher

Heidelberg: Springer

More information

Scope and Contents

Contents

Losartan is metabolized to the active carboxylic acid metabolite EXP3174 by CYP2C9. In this study, we determined the effects of the single CYP2C9*3 variant on the pharmacokinetics and pharmacodynamics of losartan.
Seven healthy Japanese subjects ( CYP2C9*1/*1, n=4 and CYP2C9*1/*3, n=3) were phenotyped with a single dose of losartan (25 mg). Bloo...

Alternative Titles

Full title

Effect of the single CYP2C93 allele on pharmacokinetics and pharmacodynamics of losartan in healthy Japanese subjects

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_71359641

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71359641

Other Identifiers

ISSN

0031-6970

E-ISSN

1432-1041

DOI

10.1007/s00228-003-0664-5

How to access this item